Cellular expression profiles of Epstein-Barr virus-transformed B-lymphoblastoid cell lines

Epstein-Barr virus (EBV) can infect human B cells and is associated with various types of B cell lymphomas. Studies on the global alterations of the cellular pathways mediated by EBV-induced B cell transformation are limited. In the present study, microarray analysis was performed following generation of two EBV-infected B-lymphoblastoid cell lines (BLCL), in which normal B cells obtained from two healthy Thai individuals and transcriptomic profiles were compared with their respective normal B cells. The two EBV-transformed BLCL datasets exhibited a high degree of similarity between their RNA expression profiles, whereas the two normal B-cell datasets did not exhibit the same degree of similarity in their RNA expression profiles. Differential gene expression analysis was performed, and the results showed that EBV infection was able to dysregulate several cellular pathways in the human B-cell genes involved in cancer and cell activation, such as the MAPK, WNT and PI3K-Akt signaling pathways, which were upregulated in the BLCL and were associated with increased cellular proliferation and immortalization of EBV-infected B cells. Expression of proteins located in the plasma membrane, which initiate a biological response to ligand binding, were also notably upregulated. Expression of genes involved in cell cycle control, the p53 signaling pathway and cellular senescence were downregulated. In conclusion, genes that were markedly upregulated by EBV included those involved in the acquisition of a tumorigenic phenotype of BLCL, which was positively correlated with several hallmarks of cancer.

[1]  Can Küçük,et al.  Genetic alterations in B cell lymphoma subtypes as potential biomarkers for noninvasive diagnosis, prognosis, therapy, and disease monitoring , 2020, Turkish journal of biology = Turk biyoloji dergisi.

[2]  A. Scialdone,et al.  Epstein–Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection , 2018, Proceedings of the National Academy of Sciences.

[3]  G. Rassidakis,et al.  AP-1 Transcription Factors as Regulators of Immune Responses in Cancer , 2019, Cancers.

[4]  J. Vilo,et al.  g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update) , 2019, Nucleic Acids Res..

[5]  Mingxiang Teng,et al.  RNA Sequencing Analyses of Gene Expression during Epstein-Barr Virus Infection of Primary B Lymphocytes , 2019, Journal of Virology.

[6]  E. Robertson,et al.  Mechanisms of B-Cell Oncogenesis Induced by Epstein-Barr Virus , 2019, Journal of Virology.

[7]  A. Dahlin,et al.  Gene expression changes in lymphoblastoid cell lines and primary B cells by dexamethasone , 2019, Pharmacogenetics and genomics.

[8]  N. Sobhani,et al.  Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer , 2019, Cells.

[9]  N. Kitkumthorn,et al.  Distribution of the Epstein‐Barr virus in the normal stomach and gastric lesions in Thai population , 2018, Journal of medical virology.

[10]  Bor-Sen Chen,et al.  Investigating genetic-and-epigenetic networks, and the cellular mechanisms occurring in Epstein–Barr virus-infected human B lymphocytes via big data mining and genome-wide two-sided NGS data identification , 2018, PloS one.

[11]  A. Malki,et al.  Epstein–Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis , 2018, Front. Oncol..

[12]  Y. Pomyen,et al.  Potential candidate treatment agents for targeting of cholangiocarcinoma identified by gene expression profile analysis , 2018, Biomedical reports.

[13]  E. Hui,et al.  Preclinical evaluation of ribociclib and its synergistic effect in combination with alpelisib in non-keratinizing nasopharyngeal carcinoma , 2018, Scientific Reports.

[14]  M. Bienkowska-Haba,et al.  Epstein-Barr virus stably confers an invasive phenotype to epithelial cells through reprogramming of the WNT pathway , 2018, Oncotarget.

[15]  Jieyu Lv,et al.  Identification of genes and pathways in nasopharyngeal carcinoma by bioinformatics analysis , 2017, Oncotarget.

[16]  Hong Yang,et al.  From big data to diagnosis and prognosis: gene expression signatures in liver hepatocellular carcinoma , 2017, PeerJ.

[17]  E. Robertson,et al.  Epstein–Barr Virus: Diseases Linked to Infection and Transformation , 2016, Front. Microbiol..

[18]  R. Li,et al.  EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop , 2016, Oncogene.

[19]  L. R. Wasil,et al.  Epstein–Barr virus LMP1 induces focal adhesions and epithelial cell migration through effects on integrin-α5 and N-cadherin , 2015, Oncogenesis.

[20]  Yu Zhao,et al.  LMP-1 induces survivin expression to inhibit cell apoptosis through the NF-κB and PI3K/Akt signaling pathways in nasal NK/T-cell lymphoma. , 2015, Oncology reports.

[21]  L. Hutt-Fletcher.  Epstein–Barr virus replicating in epithelial cells , 2014, Proceedings of the National Academy of Sciences.

[22]  H. Balfour,et al.  Age-specific prevalence of Epstein-Barr virus infection among Minnesota children: effects of race/ethnicity and family environment. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  T. Kanda,et al.  Gene expression profiling of Epstein–Barr virus-positive diffuse large B-cell lymphoma of the elderly reveals alterations of characteristic oncogenetic pathways , 2014, Cancer science.

[24]  H. Balfour,et al.  Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition. , 2013, The Journal of infectious diseases.

[25]  R. Mulherkar,et al.  Lymphoblastoid Cell lines: a Continuous in Vitro Source of Cells to Study Carcinogen Sensitivity and DNA Repair , 2012, International journal of molecular and cellular medicine.

[26]  T. Janvilisri,et al.  Nasopharyngeal Carcinoma Signaling Pathway: An Update on Molecular Biomarkers , 2012, International journal of cell biology.

[27]  Gregory F Weber,et al.  Integrins and cadherins join forces to form adhesive networks , 2011, Journal of Cell Science.

[28]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[29]  M. Rowe,et al.  Immune responses to Epstein–Barr virus: molecular interactions in the virus evasion of CD8+ T cell immunity , 2010, Microbes and infection.

[30]  L. Hutt-Fletcher,et al.  Fusion of epithelial cells by Epstein–Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins αvβ6 or αvβ8 , 2009, Proceedings of the National Academy of Sciences.

[31]  B. Han,et al.  Identification of stathmin 1 expression induced by Epstein–Barr virus in human B lymphocytes , 2007, Cell proliferation.

[32]  Christopher W. Maier,et al.  Epstein–Barr virus activates β-catenin in type III latently infected B lymphocyte lines: Association with deubiquitinating enzymes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[34]  E. Kieff,et al.  Epstein-Barr Virus-Induced Changes in B-Lymphocyte Gene Expression , 2002, Journal of Virology.

[35]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[36]  E. Robertson,et al.  Current Progress in EBV-Associated B-Cell Lymphomas. , 2017, Advances in experimental medicine and biology.

[37]  J. Jeon,et al.  Human Lymphoblastoid Cell Lines in Pharmacogenomics , 2014 .

[38]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[39]  Sandosh Padmanabhan,et al.  Handbook of Pharmacogenomics and Stratified Medicine , 2014 .

[40]  M. Melbye,et al.  The epidemiology of EBV and its association with malignant disease , 2007 .

[41]  金久 実,et al.  Post-genome informatics , 2000 .